source Post navigation Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial – Eli Lilly and Company Here’s what to know about type 1 diabetes screenings for your family – Mayo Clinic Press